FITB
60
-5
YUM
43
-6
LRCX
37
-9
BDX
56
10
EIX
70
3
MDLZ
32
-4
SWKS
38
-2
HPE
44
-2
WHR
65
-5
AME
74
-4
FMC
23
-3
WBA
43
-4
TSCO
44
-4
UPS
48
2
ABT
59
2
AZO
50
-5
GE
61
-3
CMI
64
-3
HIG
66
2
DE
42
3
FITB
60
-5
YUM
43
-6
LRCX
37
-9
BDX
56
10
EIX
70
3
MDLZ
32
-4
SWKS
38
-2
HPE
44
-2
WHR
65
-5
AME
74
-4
FMC
23
-3
WBA
43
-4
TSCO
44
-4
UPS
48
2
ABT
59
2
AZO
50
-5
GE
61
-3
CMI
64
-3
HIG
66
2
DE
42
3
Financhill
Back

The Eastern Vs. Halozyme Therapeutics Industry Stock Comparison

Sell
45

EML
The Eastern

Last Price:
27.50
Seasonality Move:
6.28%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
44.27
Seasonality Move:
17.03%
Sell
45
The Eastern (EML) is a Sell

Is The Eastern a Buy, Sell or Hold?

  • The current The Eastern [EML] share price is $27.50. The Score for EML is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
  • EML is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

EML Stock Price Chart

What is The Eastern's stock price today?

  • The The Eastern share price today is $27.50
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EML is experiencing selling pressure, which indicates risk of future bearish movement.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

EML Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.12 Sell
Relative Strength Index (14 RSI): 36.27 Sell
Chaikin Money Flow: -9575 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (28.78 - 32.8) Sell
Bollinger Bands (100): (27.7 - 31.86) Sell

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

EML Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 28.22 Sell
20-day SMA: 30.32 Sell
50-day SMA: 31.1 Sell
200-day SMA: 28.92 Sell
8-day EMA: 28.31 Sell
20-day EMA: 29.67 Sell
50-day EMA: 30.38 Sell
200-day EMA: 28.29 Sell

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

The Eastern Earnings Growth & EML Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.35 per share, and an increase next year of $0.56 per share.

The Eastern Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):